Copyright
©The Author(s) 2023.
World J Diabetes. Oct 15, 2023; 14(10): 1463-1477
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1463
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1463
Defect | Phenomenon | Ref. |
β cells failure | Insulin resistance, hyperglycaemia | Kahn[20] |
↓ GLUT 4 translocation in adipocytes | ↓ IRS-1 expression, ↓ PIP-3-kinase and PKB/Akt activities | Wilcox[23], Smith[24] |
↑ Plasma free fatty acid | Insulin resistance, ↓ lipoprotein lipase activity, hypertriglyceridaemia | Reaven et al[26], Frayne[27] |
Suppression of GLUT4 activity (muscle and liver) | Insulin dysfunction | Leroith et al[33] |
Suppression of insulin receptor activity (LIRKO) (liver) | Hyperinsulinemia, hepatic and peripheral insulin resistance, glucose intolerance, insulin dysfunction | Michael et al[37] |
Nuclear receptor translocator (ARNT) | ↓ Insulin secretion, alterations in gene expression | Gunton et al[47], Kewley et al[48] |
Suppression of IRS-2 | β-cell apoptosis, insulin resistance | Rhodes[53] |
Defect | Consequence | Ref. |
↑ Mitochondrial oxidative phosphorylation in pancreatic β-cells | ↑ROS, β-cell failure | American Diabetes Association[96], Marroqui et al[98] |
↓ Mitochondrial oxidative phosphorylation in skeletal muscle | ↓ NADH oxidoreductase activity, ↓ citrate synthase activity, ↑ fat droplets in muscle cells, insulin resistance | Petersen et al[100], Petersen et al[101], Zhang et al[106] |
↓ Size and number of mitochondria per unit | ↑ Fatty acyl-CoA and diacylglycerol, ↑ protein kinase C activities, insulin resistance | Abdul-Ghani and DeFronzo[103], Lowell and Shulman[104] |
↓ Expression of NRF-dependent genes | Insulin resistance | Lu et al[97], Patti et al[105] |
UCP2 deficiency in β-cells | ↑ Islet ATP levels, ↑ glucose-stimulated insulin secretion, obesity, β-cell failure | Zhang et al[106] |
Defect | Consequence | Ref. |
Fat buildup in insulin effector cells (liver cells, muscle cells, and adipocytes) | Insulin resistance, lipotoxicity, β-cell disruption | Muoio and Newgard [112] |
Adipose mitochondrial dysfunction | ↑ Fatty acids levels, insulin resistance | Sparks et al[113] |
Inactivated Foxa2 | Lipid deposits in the liver, insulin resistance | Wolfrum et al[114] |
↓ Malonyl Co-A in liver | ↑ Fat oxidation, ↓ circulating free fatty acids, ↑ insulin sensitivity in both muscle and liver | An et al[115] |
- Citation: Wang H, Akbari-Alavijeh S, Parhar RS, Gaugler R, Hashmi S. Partners in diabetes epidemic: A global perspective. World J Diabetes 2023; 14(10): 1463-1477
- URL: https://www.wjgnet.com/1948-9358/full/v14/i10/1463.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i10.1463